1. Home
  2. AVXL vs ESQ Comparison

AVXL vs ESQ Comparison

Compare AVXL & ESQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVXL
  • ESQ
  • Stock Information
  • Founded
  • AVXL 2004
  • ESQ 2006
  • Country
  • AVXL United States
  • ESQ United States
  • Employees
  • AVXL N/A
  • ESQ N/A
  • Industry
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • ESQ Commercial Banks
  • Sector
  • AVXL Health Care
  • ESQ Finance
  • Exchange
  • AVXL Nasdaq
  • ESQ Nasdaq
  • Market Cap
  • AVXL 956.7M
  • ESQ 886.6M
  • IPO Year
  • AVXL N/A
  • ESQ 2017
  • Fundamental
  • Price
  • AVXL $9.95
  • ESQ $95.55
  • Analyst Decision
  • AVXL Strong Buy
  • ESQ Hold
  • Analyst Count
  • AVXL 2
  • ESQ 3
  • Target Price
  • AVXL $44.00
  • ESQ $103.00
  • AVG Volume (30 Days)
  • AVXL 1.2M
  • ESQ 94.1K
  • Earning Date
  • AVXL 08-12-2025
  • ESQ 07-24-2025
  • Dividend Yield
  • AVXL N/A
  • ESQ 0.72%
  • EPS Growth
  • AVXL N/A
  • ESQ 12.45
  • EPS
  • AVXL N/A
  • ESQ 5.39
  • Revenue
  • AVXL N/A
  • ESQ $126,841,000.00
  • Revenue This Year
  • AVXL N/A
  • ESQ N/A
  • Revenue Next Year
  • AVXL N/A
  • ESQ $27.23
  • P/E Ratio
  • AVXL N/A
  • ESQ $17.73
  • Revenue Growth
  • AVXL N/A
  • ESQ 12.91
  • 52 Week Low
  • AVXL $4.93
  • ESQ $55.15
  • 52 Week High
  • AVXL $14.44
  • ESQ $106.11
  • Technical
  • Relative Strength Index (RSI)
  • AVXL 39.87
  • ESQ 47.95
  • Support Level
  • AVXL $9.90
  • ESQ $94.83
  • Resistance Level
  • AVXL $11.70
  • ESQ $99.28
  • Average True Range (ATR)
  • AVXL 0.70
  • ESQ 2.70
  • MACD
  • AVXL -0.23
  • ESQ -0.05
  • Stochastic Oscillator
  • AVXL 1.62
  • ESQ 57.18

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.

About ESQ Esquire Financial Holdings Inc.

Esquire Financial Holdings Inc is a financial holding company. Through its subsidiary, the company operates as a full-service commercial bank dedicated to serving the financial needs of the legal industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The Bank offers tailored products and solutions to the legal community and their clients as well as dynamic and flexible payment processing solutions to small business owners. Banking products offered for businesses and consumers include checking, savings, money market, and time deposits; a wide range of commercial and consumer loans, as well as customary banking services. In addition, it operates a payment processing platform through third-party independent sales organizations.

Share on Social Networks: